Showing results (681-690 of 827) with videos related to

Sort By:
Pageof 83
Proceedings of the National Academy of Sciences of the United States of America|June 6, 1995
Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives)J Balzarini, M J Pérez-Pérez, S Vélazquez, et al.
Journal of Colloid and Interface Science|September 8, 2024
Liquid crystal nanoparticles for oral combination antibiotic therapies: A strategy towards protecting commensal gut bacteria during treatmentXiguo He, Philip A Karlsson, Ruisheng Xiong, et al.
Plos One|February 25, 2021
The cost-effectiveness of prostate cancer screening using the Stockholm3 testAndreas A Karlsson, Shuang Hao, Alexandra Jauhiainen, et al.
Journal of Medicinal Chemistry|August 28, 1999
5'-Phosphoramidates and 5'-diphosphates of 2'-O-allyl-beta-D-arabinofuranosyluracil, -cytosine, and -adenine: inhibition of ribonucleotide reductaseS Manfredini, P G Baraldi, E Durini, et al.
Infection and Immunity|November 24, 1999
Helicobacter pylori and neutrophils: sialic acid-dependent binding to various isolated glycoconjugatesH Miller-Podraza, J Bergström, S Teneberg, et al.
Journal of Virology|September 16, 2011
Increased pathogenicity of a reassortant 2009 pandemic H1N1 influenza virus containing an H5N1 hemagglutininTroy D Cline, Erik A Karlsson, Pamela Freiden, et al.
Archives of Biochemistry and Biophysics|August 15, 1984
Lewis blood group antigens defined by monoclonal anti-colon carcinoma antibodiesM Blaszczyk, G C Hansson, K A Karlsson, et al.
The Journal of General Virology|January 8, 2021
Assessment of inactivation procedures for SARS-CoV-2Heidi Auerswald, Sokhoun Yann, Sokha Dul, et al.
Molecular Immunology|April 1, 1992
Characterisation of the anti-A antibody response following an ABO incompatible (A2 to O) kidney transplantationL Rydberg, M E Breimer, J Holgersson, et al.
British Journal of Pharmacology|June 1, 1996
Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformerJ E Souness, M Griffin, C Maslen, et al.
Pageof 83